Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma
Clinical trial NCT03988647 · TERMINATED
Trial details
- NCT number
- NCT03988647
- Sponsor
- Stanford University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2020-11-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.